Robeco Institutional Asset Management B.V. Sells 4,883 Shares of Globe Life Inc. $GL

Robeco Institutional Asset Management B.V. lessened its stake in Globe Life Inc. (NYSE:GL - Free Report) by 30.8% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 10,980 shares of the company's stock after selling 4,883 shares during the period. Robeco Institutional Asset Management B.V.'s holdings in Globe Life were worth $1,365,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds also recently added to or reduced their stakes in GL. Pallas Capital Advisors LLC grew its stake in Globe Life by 47.4% in the first quarter. Pallas Capital Advisors LLC now owns 7,432 shares of the company's stock valued at $979,000 after purchasing an additional 2,391 shares during the last quarter. GAMMA Investing LLC grew its stake in Globe Life by 18.8% in the first quarter. GAMMA Investing LLC now owns 5,936 shares of the company's stock valued at $782,000 after purchasing an additional 941 shares during the last quarter. Fiduciary Financial Group LLC purchased a new position in Globe Life in the first quarter valued at about $268,000. Livforsakringsbolaget Skandia Omsesidigt purchased a new position in Globe Life in the first quarter valued at about $2,239,000. Finally, Handelsbanken Fonder AB grew its stake in Globe Life by 93.0% in the first quarter. Handelsbanken Fonder AB now owns 41,500 shares of the company's stock valued at $5,466,000 after purchasing an additional 20,000 shares during the last quarter. Hedge funds and other institutional investors own 81.61% of the company's stock.

Insider Transactions at Globe Life

In other Globe Life news, CEO Frank M. Svoboda sold 12,500 shares of the business's stock in a transaction that occurred on Thursday, July 31st. The stock was sold at an average price of $141.38, for a total value of $1,767,250.00. Following the completion of the transaction, the chief executive officer directly owned 32,747 shares of the company's stock, valued at approximately $4,629,770.86. The trade was a 27.63% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO James Matthew Darden sold 33,270 shares of the business's stock in a transaction that occurred on Friday, July 25th. The shares were sold at an average price of $135.59, for a total value of $4,511,079.30. Following the completion of the transaction, the chief executive officer directly owned 49,842 shares of the company's stock, valued at $6,758,076.78. The trade was a 40.03% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 84,722 shares of company stock worth $11,733,793. 1.97% of the stock is owned by company insiders.

Analyst Ratings Changes

Several equities analysts have issued reports on the company. BMO Capital Markets reiterated a "market perform" rating and issued a $149.00 target price (up previously from $114.00) on shares of Globe Life in a research note on Wednesday, July 30th. Weiss Ratings restated a "buy (b-)" rating on shares of Globe Life in a research note on Saturday, September 27th. Keefe, Bruyette & Woods boosted their price target on Globe Life from $145.00 to $155.00 and gave the stock an "outperform" rating in a research note on Monday, July 28th. Wells Fargo & Company boosted their price target on Globe Life from $144.00 to $150.00 and gave the stock an "overweight" rating in a research note on Friday, July 25th. Finally, Morgan Stanley set a $179.00 price target on Globe Life and gave the stock an "overweight" rating in a research note on Tuesday. One equities research analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $153.18.

Globe Life Trading Up 1.3%

Globe Life stock opened at $135.70 on Wednesday. The company has a quick ratio of 0.06, a current ratio of 0.06 and a debt-to-equity ratio of 0.43. Globe Life Inc. has a 52 week low of $100.27 and a 52 week high of $147.83. The company has a market capitalization of $10.99 billion, a price-to-earnings ratio of 10.85 and a beta of 0.55. The stock has a 50-day moving average price of $140.43 and a 200 day moving average price of $128.66.

Globe Life (NYSE:GL - Get Free Report) last released its earnings results on Wednesday, July 23rd. The company reported $3.27 EPS for the quarter, topping analysts' consensus estimates of $3.25 by $0.02. Globe Life had a return on equity of 21.24% and a net margin of 18.11%.The firm had revenue of $1.48 billion during the quarter, compared to the consensus estimate of $1.50 billion. During the same quarter in the previous year, the company posted $2.97 earnings per share. The company's revenue was up 2.9% compared to the same quarter last year. Globe Life has set its FY 2025 guidance at 14.250-14.650 EPS. Sell-side analysts anticipate that Globe Life Inc. will post 13.87 EPS for the current year.

Globe Life Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, October 3rd will be issued a dividend of $0.27 per share. The ex-dividend date of this dividend is Friday, October 3rd. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.8%. Globe Life's payout ratio is 8.63%.

Globe Life Profile

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.